Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Interim Management Statement

7th Aug 2012 14:55

RNS Number : 5067J
United Drug PLC
07 August 2012
 



United Drug plc

Notice of Interim Management Statement

 

United Drug plc ("the Company") will issue its next Interim Management Statement at 7:00 a.m. on Tuesday, 14 August 2012.

 

The Company will also host a conference call for investors and analystsat 8.30 a.m. (BST) on Tuesday, 14 August 2012 to discuss this statement. The dial-in details are as follows:

 

Ireland: +353 (0)1 431 9648

UK/International: +44 (0) 1452 555 566

US: +1 631 510 7498

Access Code: 16692215

 

 

Ends Tuesday, 7 August 2012.

 

Contact:

Karen Geoghegan

Tel: +353-1-4637720

 

 

About United Drug plc

 

Listed on the Stock Exchanges in London and Dublin, United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in the UK, Ireland, the Netherlands, Belgium and the USA. 

 

The Company operates across three divisions, Healthcare Supply Chain, Sales, Marketing & Medical, and Packaging & Specialty.

 

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. Through its medical & scientific operations, United Drug provides sales & marketing and technical service solutions, including contract distribution services to a wide range of medical & scientific equipment & consumable manufacturers, with a market leading position in Ireland and an emerging presence in the UK.

 

In the Sales, Marketing & Medical division United Drug is the leading provider of contract sales outsourcing services to pharmaceutical manufacturers in the UK and Ireland and has a growing presence in the US market. United Drug also provides related marketing services to pharmaceutical manufacturers in each of these markets.

 

In the Packaging & Specialty division United Drug is a leading international provider of pharmaceutical contract packaging services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution and homecare services in the UK and Ireland.

 

For more information go to www.united-drug.com. 

 

 

 

 

 

 

 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISESSLFDWFESEIA

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00